Skip to main content

$0.080 -0.005 (-5.88%)

High

$0.08

Low

$0.08

Trades

3

Turnover

$5,284

Volume

65,268
30 June 2023 at 10:32am
Register to track OIL and receive email alerts.

Optiscan Platform Highly Accurate for Oral Cancer Diagnosis

StockBot

416,823 posts

OIL released this announcement to the ASX on 14 March 2023, 8:28. The announcement is marked as price sensitive, and is 2 page(s) in length and 108.11kb in size.

You can view all announcements from OIL and see how they appear on a price chart on the announcements page.

At the date of this announcement, OIL was 0.000% short sold according to ASIC data. It was ranked the 633rd most shorted stock on the ASX. It is now ranked as the 594th most shorted stock on the ASX with 0.001% of total shares short sold as of the latest reported data (01 December 2025).

Other Recent Announcements from OIL
Update - Proposed issue of securities - OIL 26 June 2023, 11:18
Entitlement Offer Extension to Closing Date 26 June 2023, 11:13
Entitlement Offer - Letter to Ineligible Shareholders 7 June 2023, 11:37
Optiscan Platform Highly Accurate for Oral Cancer Diagnosis 14 March 2023, 8:28
Optiscan Intends to pursue De Novo Pathway for InVivage 2 March 2023, 12:32
OIL Appendix 4D and 31 December 2022 Half-year report 27 February 2023, 12:57
Optiscan partners with Prolucid to develop AI Algorithms 30 January 2023, 8:46
You must login or register to post a comment.

You must be logged in to post a reply.

Register to track OIL and receive email alerts.